Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2021

Open Access 01-02-2021 | Research Article

Critical appraisal of tobacco dependence treatment guidelines

Authors: Maguy Saffouh El Hajj, Myriam Jaam, Saba Abdal Salam Sheikh Ali, Rana Saleh, Ahmed Awaisu, Bridget Paravattil, Kyle John Wilby

Published in: International Journal of Clinical Pharmacy | Issue 1/2021

Login to get access

Abstract

Background Tobacco use is a leading preventable cause of morbidity and mortality globally. Clinical practice guidelines for the treatment of tobacco use dependence are of varied scope and quality, making it challenging for users to select and apply recommendations. Objective The study objective is to identify and critically appraise the quality of existing clinical practice guidelines for tobacco cessation. Setting The study occurred between collaborative academic institutions located in Qatar and New Zealand. Methods A systematic literature search was performed for the period 2006–2018 through the following databases: PubMed, EMBASE, CINAHL, ISI Web of Science, Scopus, National Guideline Clearing House, Campbell Library, Health System Evidence, Joanna Briggs Institute Evidence-Based Practice Database, Academic Search Complete, ProQuest, PROSPERO, and Google Scholar. Relevant professional societies’ and health agencies’ websites were also searched. Two reviewers independently extracted and assessed guidelines’ quality using Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument. Main outcome measure Standardized domain scores according to the AGREE II instrument. Results 7741 hits were identified. After removing duplicates and screening, 24 guidelines were included. Highest guideline quality was for National Institute for Health and Care Excellence (NICE) guideline with an overall ranking score of 87.56% and least quality was for Japanese Circulation Society Joint Working Group with an overall score of 29.34%. Domain 4 of AGREE II (clarity of presentation) had the highest average quality score (70.95%), while the lowest average quality scores were for Domain 2 (Rigour of Development) (50.21%) and Domain 5 (Applicability) (45.05%). Conclusion Seven guidelines were judged to be of high quality (overall score of ≥ 70%). Future guidelines for tobacco dependence treatment should use rigorous methods of development and provide applicable recommendations.
Appendix
Available only for authorised users
Literature
1.
go back to reference West R. Tobacco smoking: health impact, prevalence, correlates and interventions. Psychol Health. 2017;32(8):1018–36.CrossRef West R. Tobacco smoking: health impact, prevalence, correlates and interventions. Psychol Health. 2017;32(8):1018–36.CrossRef
2.
go back to reference GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories: a systematic analysis from the Global Burden of Disease Study. Lancet. 2017;389(10082):1885–906.CrossRef GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories: a systematic analysis from the Global Burden of Disease Study. Lancet. 2017;389(10082):1885–906.CrossRef
3.
go back to reference Ekpu VU, Brown AK. The economic impact of smoking and of reducing smoking prevalence: review of evidence. Tob Use Insights. 2015;8:1–35.CrossRef Ekpu VU, Brown AK. The economic impact of smoking and of reducing smoking prevalence: review of evidence. Tob Use Insights. 2015;8:1–35.CrossRef
4.
go back to reference Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. preventive services task force. Ann Intern Med. 2015;163(8):608–21.CrossRef Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. preventive services task force. Ann Intern Med. 2015;163(8):608–21.CrossRef
5.
go back to reference Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:Cd009329. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:Cd009329.
6.
go back to reference Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2015;12:Cd010078. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2015;12:Cd010078.
7.
go back to reference Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2012;10:Cd008286.PubMed Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2012;10:Cd008286.PubMed
8.
go back to reference Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527–30.CrossRef Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527–30.CrossRef
9.
go back to reference Feder G, Eccles M, Grol R, Griffiths C, Grimshaw J. Clinical guidelines: using clinical guidelines. BMJ. 1999;318(7185):728–30.CrossRef Feder G, Eccles M, Grol R, Griffiths C, Grimshaw J. Clinical guidelines: using clinical guidelines. BMJ. 1999;318(7185):728–30.CrossRef
10.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;151(4):264–9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;151(4):264–9.
11.
go back to reference Brouwers M, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–42.CrossRef Brouwers M, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–42.CrossRef
12.
go back to reference Reis I, Fortuna P, Ascenção R, Costa J, Bugalho A, Carneiro AV. Clinical practice guideline on smoking cessation. Portugal centre for evidence based medicine university of Lisbon school of medicine, Medicine. 2008. Reis I, Fortuna P, Ascenção R, Costa J, Bugalho A, Carneiro AV. Clinical practice guideline on smoking cessation. Portugal centre for evidence based medicine university of Lisbon school of medicine, Medicine. 2008.
13.
go back to reference van Schayck OC, Pinnock H, Ostrem A, Litt J, Tomlins R, Williams S, et al. IPCRG consensus statement: tackling the smoking epidemic—practical guidance for primary care. Prim Care Respir J. 2008;17(3):185–93.CrossRef van Schayck OC, Pinnock H, Ostrem A, Litt J, Tomlins R, Williams S, et al. IPCRG consensus statement: tackling the smoking epidemic—practical guidance for primary care. Prim Care Respir J. 2008;17(3):185–93.CrossRef
14.
go back to reference Zwar N, Richmond R, Borland R, Peters M, Litt J, Bell J, et al. Supporting smoking cessation: a guide for health professionals. Melbourne: The Royal Australian College of General Practitioners; 2011. Zwar N, Richmond R, Borland R, Peters M, Litt J, Bell J, et al. Supporting smoking cessation: a guide for health professionals. Melbourne: The Royal Australian College of General Practitioners; 2011.
15.
go back to reference Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;143(5 Suppl):e61S–77S. Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;143(5 Suppl):e61S–77S.
16.
go back to reference Lingford-Hughes A, Welch S, Peters L, Nutt D. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol. 2012;26(7):899–952.CrossRef Lingford-Hughes A, Welch S, Peters L, Nutt D. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol. 2012;26(7):899–952.CrossRef
17.
go back to reference Chan K, Chandler J, Cheong K, Giam PE, Kanagalingam D, Lee LL, et al. Health promotion board-ministry of health clinical practice guidelines: treating tobacco use and dependence. Singapore Med J. 2013;54(7):411–5.CrossRef Chan K, Chandler J, Cheong K, Giam PE, Kanagalingam D, Lee LL, et al. Health promotion board-ministry of health clinical practice guidelines: treating tobacco use and dependence. Singapore Med J. 2013;54(7):411–5.CrossRef
18.
go back to reference WHO. WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy. Switzerland: World Health Organization. 2013. WHO. WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy. Switzerland: World Health Organization. 2013.
19.
go back to reference MoHM Disease Control Division. Clinical practice guidelines on treatment of tobacco use disorder. Malaysia: Tobacco Control Unit & FCTC Secretariat, Non-Communicable Disease Section; 2016. MoHM Disease Control Division. Clinical practice guidelines on treatment of tobacco use disorder. Malaysia: Tobacco Control Unit & FCTC Secretariat, Non-Communicable Disease Section; 2016.
20.
go back to reference Tønnesen P, Carrozzi L, Fagerström KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J. 2007;29(2):390–417.CrossRef Tønnesen P, Carrozzi L, Fagerström KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J. 2007;29(2):390–417.CrossRef
21.
go back to reference Kelly Mike, Morgan Antony, Owen Lesley, Jones Dylan, Peploe Karen, Doohan Emma, et al. Smoking: stopping in pregnancy and after childbirth. United Kingdom: NICE; 2018. Kelly Mike, Morgan Antony, Owen Lesley, Jones Dylan, Peploe Karen, Doohan Emma, et al. Smoking: stopping in pregnancy and after childbirth. United Kingdom: NICE; 2018.
22.
go back to reference JCS Joint Working Group. Guidelines for smoking cessation (JCS 2010)-digest version. Circ J. 2012;76(4):1024–43.CrossRef JCS Joint Working Group. Guidelines for smoking cessation (JCS 2010)-digest version. Circ J. 2012;76(4):1024–43.CrossRef
23.
go back to reference Kelly Mike, Younger Tricia, Ellis Simon, Shearn Pete, Killoran Amanda, Sheppard Linda, et al. Smoking: acute, maternity and mental health services. United Kingdom: NICE; 2013. Kelly Mike, Younger Tricia, Ellis Simon, Shearn Pete, Killoran Amanda, Sheppard Linda, et al. Smoking: acute, maternity and mental health services. United Kingdom: NICE; 2013.
24.
go back to reference McRobbie H, Baiabe H, Barlow D, Beverley K, Bullen DC, Eadie S, et al. Background and recommendations of the New Zealand guidelines for helping people to stop smoking. New Zealand: Ministry of Health; 2014. McRobbie H, Baiabe H, Barlow D, Beverley K, Bullen DC, Eadie S, et al. Background and recommendations of the New Zealand guidelines for helping people to stop smoking. New Zealand: Ministry of Health; 2014.
25.
go back to reference National Center for Smoking Cessation and Training. Local stop smoking services: services and delivery guidance 2014. England: National center for smoking cessation and training; 2014. National Center for Smoking Cessation and Training. Local stop smoking services: services and delivery guidance 2014. England: National center for smoking cessation and training; 2014.
26.
go back to reference Al-Katheeri HA, Alfehaidi AS, Siddig IO, Garcia MB, AlHuneiti RAS, Jaran M. Clinical guidelines for the state of Qatar: management of tobacco dependency. Qatar: Ministry of Public Health; 2016. Al-Katheeri HA, Alfehaidi AS, Siddig IO, Garcia MB, AlHuneiti RAS, Jaran M. Clinical guidelines for the state of Qatar: management of tobacco dependency. Qatar: Ministry of Public Health; 2016.
27.
go back to reference Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB. Smoking cessation. USA: National comprehensive cancer network; 2017. Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB. Smoking cessation. USA: National comprehensive cancer network; 2017.
28.
go back to reference Van Schayck OCP, Williams S, Barchilon V, Baxter N, Jawad M, Katsaounou PA, et al. Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG. NPJ Prim Care Respir Med. 2017;27(1):38.CrossRef Van Schayck OCP, Williams S, Barchilon V, Baxter N, Jawad M, Katsaounou PA, et al. Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG. NPJ Prim Care Respir Med. 2017;27(1):38.CrossRef
29.
go back to reference Hopkins S, Macleod J, McDaid D, Lines S, Chapman R, Milne R, et al. Stop Smoking cervices. England: NICE; 2018. Hopkins S, Macleod J, McDaid D, Lines S, Chapman R, Milne R, et al. Stop Smoking cervices. England: NICE; 2018.
30.
go back to reference Weel Cv, Bladeren FAv, Coebergh JWW, Drenthen AJM, Kaandorp CJE, Schippers GM, et al. Guideline: Treatment of tobacco dependence. Netherlands: The programme evidence-based guideline development of the Dutch society of medical specialists, Dutch institute for healthcare. 2006. Weel Cv, Bladeren FAv, Coebergh JWW, Drenthen AJM, Kaandorp CJE, Schippers GM, et al. Guideline: Treatment of tobacco dependence. Netherlands: The programme evidence-based guideline development of the Dutch society of medical specialists, Dutch institute for healthcare. 2006.
31.
go back to reference Selby P, Bean T, Els C, Ferrence R, Garcia J, McDonald P, et al. Canadian smoking cessation clinical practice guideline. Canada: Can-Adapt; 2012. Selby P, Bean T, Els C, Ferrence R, Garcia J, McDonald P, et al. Canadian smoking cessation clinical practice guideline. Canada: Can-Adapt; 2012.
32.
go back to reference van Zyl-Smit RN, Allwood B, Stickells D, Symons G, Abdool-Gaffar S, Murphy K, et al. South African tobacco smoking cessation clinical practice guideline. 2013;103(11):869–76. van Zyl-Smit RN, Allwood B, Stickells D, Symons G, Abdool-Gaffar S, Murphy K, et al. South African tobacco smoking cessation clinical practice guideline. 2013;103(11):869–76.
33.
go back to reference Batra A, Petersen KU, Hoch E, Andreas S, Bartsch G, Gohlke H, et al. S3 guideline: screening, siagnostics, and treatment of harmful and addictive tobacco use”. SUCHT. 2016;62(3):139–52.CrossRef Batra A, Petersen KU, Hoch E, Andreas S, Bartsch G, Gohlke H, et al. S3 guideline: screening, siagnostics, and treatment of harmful and addictive tobacco use”. SUCHT. 2016;62(3):139–52.CrossRef
34.
go back to reference Siu AL. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163(8):622–34.CrossRef Siu AL. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163(8):622–34.CrossRef
35.
go back to reference Fiore M, Jaén CR, Baker TB, Bailey WC, Bennett G, Benowitz NL, et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. public health service report. Am J Prev Med. 2008;35(2):158–76.CrossRef Fiore M, Jaén CR, Baker TB, Bailey WC, Bennett G, Benowitz NL, et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. public health service report. Am J Prev Med. 2008;35(2):158–76.CrossRef
37.
go back to reference Molino C, Leite-Santos NC, Gabriel FC, Wainberg SK, Vasconcelos LP, Mantovani-Silva RA, et al. Factors associated with high-quality guidelines for the pharmacologic management of chronic diseases in primary care: a systematic review. JAMA Intern Med. 2019;179(4):553–60.CrossRef Molino C, Leite-Santos NC, Gabriel FC, Wainberg SK, Vasconcelos LP, Mantovani-Silva RA, et al. Factors associated with high-quality guidelines for the pharmacologic management of chronic diseases in primary care: a systematic review. JAMA Intern Med. 2019;179(4):553–60.CrossRef
38.
go back to reference Farghali AA, Al-Khawaja R, Madi L, Elbardissy A, Hamdy HM, Wilby KJ. Rigorous method to assess quality and generalizability of clinical practice guidelines. Can J Hosp Pharm. 2014;67(5):397–8.PubMedPubMedCentral Farghali AA, Al-Khawaja R, Madi L, Elbardissy A, Hamdy HM, Wilby KJ. Rigorous method to assess quality and generalizability of clinical practice guidelines. Can J Hosp Pharm. 2014;67(5):397–8.PubMedPubMedCentral
39.
go back to reference Uzeloto JS, Moseley AM, Elkins MR, Franco MR, Pinto RZ, Freire A, et al. The quality of clinical practice guidelines for chronic respiratory diseases and the reliability of the AGREE II: an observational study. Int J Physiother. 2017;103(4):439–45.CrossRef Uzeloto JS, Moseley AM, Elkins MR, Franco MR, Pinto RZ, Freire A, et al. The quality of clinical practice guidelines for chronic respiratory diseases and the reliability of the AGREE II: an observational study. Int J Physiother. 2017;103(4):439–45.CrossRef
40.
go back to reference Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization. 2003;139(6):493–8. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization. 2003;139(6):493–8.
41.
go back to reference Grol R, Cluzeau FA, Burgers JS. Clinical practice guidelines: towards better quality guidelines and increased international collaboration. 2003;89(Suppl 1):S4–8. Grol R, Cluzeau FA, Burgers JS. Clinical practice guidelines: towards better quality guidelines and increased international collaboration. 2003;89(Suppl 1):S4–8.
42.
go back to reference Gagliardi AR, Brouwers MC. Do guidelines offer implementation advice to target users? A systematic review of guideline applicability. 2015;5(2):e007047. Gagliardi AR, Brouwers MC. Do guidelines offer implementation advice to target users? A systematic review of guideline applicability. 2015;5(2):e007047.
43.
go back to reference Mirzaei M, Aspin C, Essue B, Jeon YH, Dugdale P, Usherwood T, et al. A patient-centred approach to health service delivery: improving health outcomes for people with chronic illness. BMC Health Serv Res. 2013;13:251.CrossRef Mirzaei M, Aspin C, Essue B, Jeon YH, Dugdale P, Usherwood T, et al. A patient-centred approach to health service delivery: improving health outcomes for people with chronic illness. BMC Health Serv Res. 2013;13:251.CrossRef
Metadata
Title
Critical appraisal of tobacco dependence treatment guidelines
Authors
Maguy Saffouh El Hajj
Myriam Jaam
Saba Abdal Salam Sheikh Ali
Rana Saleh
Ahmed Awaisu
Bridget Paravattil
Kyle John Wilby
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01110-4

Other articles of this Issue 1/2021

International Journal of Clinical Pharmacy 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.